Literature DB >> 28329057

Coronary Artery Calcification and Risk of Cardiovascular Disease and Death Among Patients With Chronic Kidney Disease.

Jing Chen1, Matthew J Budoff2, Muredach P Reilly3, Wei Yang4, Sylvia E Rosas5, Mahboob Rahman6, Xiaoming Zhang4, Jason A Roy4, Eva Lustigova7, Lisa Nessel4, Virginia Ford8, Dominic Raj9, Anna C Porter10, Elsayed Z Soliman11, Jackson T Wright6, Myles Wolf12, Jiang He1.   

Abstract

Importance: Coronary artery calcification (CAC) is highly prevalent in dialysis-naive patients with chronic kidney disease (CKD). However, there are sparse data on the association of CAC with subsequent risk of cardiovascular disease and all-cause mortality in this population. Objective: To study the prospective association of CAC with risk of cardiovascular disease and all-cause mortality among dialysis-naive patients with CKD. Design, Setting, and Participants: The prospective Chronic Renal Insufficiency Cohort study recruited adults with an estimated glomerular filtration rate of 20 to 70 mL/min/1.73 m2 from 7 clinical centers in the United States. There were 1541 participants without cardiovascular disease at baseline who had CAC scores. Exposures: Coronary artery calcification was assessed using electron-beam or multidetector computed tomography. Main Outcomes and Measures: Incidence of cardiovascular disease (including myocardial infarction, heart failure, and stroke) and all-cause mortality were reported every 6 months and confirmed by medical record adjudication.
Results: During an average follow-up of 5.9 years in 1541 participants aged 21 to 74 years, there were 188 cardiovascular disease events (60 cases of myocardial infarction, 120 heart failures, and 27 strokes; patients may have had >1 event) and 137 all-cause deaths. In Cox proportional hazards models adjusted for age, sex, race, clinical site, education level, physical activity, total cholesterol level, high-density lipoprotein cholesterol level, systolic blood pressure, use of antihypertensive treatment, current cigarette smoking, diabetes status, body mass index, C-reactive protein level, hemoglobin A1c level, phosphorus level, troponin T level, log N-terminal pro-B-type natriuretic peptide level, fibroblast growth factor 23 level, estimated glomerular filtration rate, and proteinuria, the hazard ratios associated with per 1 SD log of CAC were 1.40 (95% CI, 1.16-1.69; P < .001) for cardiovascular disease, 1.44 (95% CI, 1.02-2.02; P = .04) for myocardial infarction, 1.39 (95% CI, 1.10-1.76; P = .006) for heart failure, and 1.19 (95% CI, 0.94-1.51; P = .15) for all-cause mortality. In addition, inclusion of CAC score led to an increase in the C statistic of 0.02 (95% CI, 0-0.09; P < .001) for predicting cardiovascular disease over use of all the above-mentioned established and novel cardiovascular disease risk factors. Conclusions and Relevance: Coronary artery calcification is independently and significantly related to the risks of cardiovascular disease, myocardial infarction, and heart failure in patients with CKD. In addition, CAC improves risk prediction for cardiovascular disease, myocardial infarction, and heart failure over use of established and novel cardiovascular disease risk factors among patients with CKD; however, the changes in the C statistic are small.

Entities:  

Mesh:

Year:  2017        PMID: 28329057      PMCID: PMC5798875          DOI: 10.1001/jamacardio.2017.0363

Source DB:  PubMed          Journal:  JAMA Cardiol            Impact factor:   14.676


  33 in total

Review 1.  Vascular calcification: pathobiology of a multifaceted disease.

Authors:  Linda L Demer; Yin Tintut
Journal:  Circulation       Date:  2008-06-03       Impact factor: 29.690

2.  Coronary calcification in chronic kidney disease: morphology, mechanisms and mortality.

Authors:  Alisha N Wade; Muredach P Reilly
Journal:  Clin J Am Soc Nephrol       Date:  2009-11-19       Impact factor: 8.237

3.  Subclinical atherosclerosis measures for cardiovascular prediction in CKD.

Authors:  Kunihiro Matsushita; Yingying Sang; Shoshana H Ballew; Michael Shlipak; Ronit Katz; Sylvia E Rosas; Carmen A Peralta; Mark Woodward; Holly J Kramer; David R Jacobs; Mark J Sarnak; Josef Coresh
Journal:  J Am Soc Nephrol       Date:  2014-08-21       Impact factor: 10.121

4.  Coronary artery calcium score and risk classification for coronary heart disease prediction.

Authors:  Tamar S Polonsky; Robyn L McClelland; Neal W Jorgensen; Diane E Bild; Gregory L Burke; Alan D Guerci; Philip Greenland
Journal:  JAMA       Date:  2010-04-28       Impact factor: 56.272

5.  Estimating GFR among participants in the Chronic Renal Insufficiency Cohort (CRIC) Study.

Authors:  Amanda Hyre Anderson; Wei Yang; Chi-yuan Hsu; Marshall M Joffe; Mary B Leonard; Dawei Xie; Jing Chen; Tom Greene; Bernard G Jaar; Patricia Kao; John W Kusek; J Richard Landis; James P Lash; Raymond R Townsend; Matthew R Weir; Harold I Feldman
Journal:  Am J Kidney Dis       Date:  2012-06-02       Impact factor: 8.860

6.  Relation between kidney function, proteinuria, and adverse outcomes.

Authors:  Brenda R Hemmelgarn; Braden J Manns; Anita Lloyd; Matthew T James; Scott Klarenbach; Robert R Quinn; Natasha Wiebe; Marcello Tonelli
Journal:  JAMA       Date:  2010-02-03       Impact factor: 56.272

7.  Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization.

Authors:  Alan S Go; Glenn M Chertow; Dongjie Fan; Charles E McCulloch; Chi-yuan Hsu
Journal:  N Engl J Med       Date:  2004-09-23       Impact factor: 91.245

8.  Incidence and progression of coronary calcification in chronic kidney disease: the Multi-Ethnic Study of Atherosclerosis.

Authors:  Bryan R Kestenbaum; Kathryn L Adeney; Ian H de Boer; Joachim H Ix; Michael G Shlipak; David S Siscovick
Journal:  Kidney Int       Date:  2009-08-19       Impact factor: 10.612

9.  Risk factors for coronary artery calcium among patients with chronic kidney disease (from the Chronic Renal Insufficiency Cohort Study).

Authors:  Jiang He; Muredach Reilly; Wei Yang; Jing Chen; Alan S Go; James P Lash; Mahboob Rahman; Chris DeFilippi; Crystal Gadegbeku; Radhika Kanthety; Kaixiang Tao; L Lee Hamm; Akinlolu Ojo; Ray Townsend; Matthew Budoff
Journal:  Am J Cardiol       Date:  2012-09-14       Impact factor: 2.778

Review 10.  Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention.

Authors:  Ron T Gansevoort; Ricardo Correa-Rotter; Brenda R Hemmelgarn; Tazeen H Jafar; Hiddo J Lambers Heerspink; Johannes F Mann; Kunihiro Matsushita; Chi Pang Wen
Journal:  Lancet       Date:  2013-05-31       Impact factor: 79.321

View more
  89 in total

1.  Serum Calcification Propensity and Coronary Artery Calcification Among Patients With CKD: The CRIC (Chronic Renal Insufficiency Cohort) Study.

Authors:  Joshua D Bundy; Xuan Cai; Julia J Scialla; Mirela A Dobre; Jing Chen; Chi-Yuan Hsu; Mary B Leonard; Alan S Go; Panduranga S Rao; James P Lash; Raymond R Townsend; Harold I Feldman; Ian H de Boer; Geoffrey A Block; Myles Wolf; Edward R Smith; Andreas Pasch; Tamara Isakova
Journal:  Am J Kidney Dis       Date:  2019-03-29       Impact factor: 8.860

2.  Cardiovascular disease: Coronary artery calcification predicts risk of CVD in patients with CKD.

Authors:  Paolo Raggi
Journal:  Nat Rev Nephrol       Date:  2017-05-08       Impact factor: 28.314

3.  Deoxycholic Acid, a Metabolite of Circulating Bile Acids, and Coronary Artery Vascular Calcification in CKD.

Authors:  Anna Jovanovich; Tamara Isakova; Geoffrey Block; Jason Stubbs; Gerard Smits; Michel Chonchol; Makoto Miyazaki
Journal:  Am J Kidney Dis       Date:  2017-08-09       Impact factor: 8.860

4.  A Randomized Trial of Magnesium Oxide and Oral Carbon Adsorbent for Coronary Artery Calcification in Predialysis CKD.

Authors:  Yusuke Sakaguchi; Takayuki Hamano; Yoshitsugu Obi; Chikako Monden; Tatsufumi Oka; Satoshi Yamaguchi; Isao Matsui; Nobuhiro Hashimoto; Ayumi Matsumoto; Karin Shimada; Yoshitsugu Takabatake; Atsushi Takahashi; Jun-Ya Kaimori; Toshiki Moriyama; Ryohei Yamamoto; Masaru Horio; Koichi Yamamoto; Ken Sugimoto; Hiromi Rakugi; Yoshitaka Isaka
Journal:  J Am Soc Nephrol       Date:  2019-04-29       Impact factor: 10.121

5.  Sex disparities and adverse cardiovascular and kidney outcomes in patients with chronic kidney disease: results from the KNOW-CKD.

Authors:  Chan-Young Jung; Ga Young Heo; Jung Tak Park; Young Su Joo; Hyung Woo Kim; Hyunsun Lim; Tae Ik Chang; Ea Wha Kang; Tae-Hyun Yoo; Shin-Wook Kang; Joongyub Lee; Soo Wan Kim; Yun Kyu Oh; Ji Yong Jung; Kook-Hwan Oh; Curie Ahn; Seung Hyeok Han
Journal:  Clin Res Cardiol       Date:  2021-05-18       Impact factor: 5.460

6.  Risk factors for progression of coronary artery calcification in patients with chronic kidney disease: The CRIC study.

Authors:  Joshua D Bundy; Jing Chen; Wei Yang; Matthew Budoff; Alan S Go; Juan E Grunwald; Radhakrishna R Kallem; Wendy S Post; Muredach P Reilly; Ana C Ricardo; Sylvia E Rosas; Xiaoming Zhang; Jiang He
Journal:  Atherosclerosis       Date:  2018-02-10       Impact factor: 5.162

Review 7.  Role of Coronary Calcium Score to Identify Candidates for ASCVD Prevention.

Authors:  Hong Loan Nguyen; Jing Liu; Maygen Del Castillo; Tina Shah
Journal:  Curr Atheroscler Rep       Date:  2019-11-21       Impact factor: 5.113

Review 8.  Cardiovascular risk factors in children on dialysis: an update.

Authors:  Uwe Querfeld; Franz Schaefer
Journal:  Pediatr Nephrol       Date:  2018-10-31       Impact factor: 3.714

9.  Serum Calcification Propensity and Clinical Events in CKD.

Authors:  Joshua D Bundy; Xuan Cai; Rupal C Mehta; Julia J Scialla; Ian H de Boer; Chi-Yuan Hsu; Alan S Go; Mirela A Dobre; Jing Chen; Panduranga S Rao; Mary B Leonard; James P Lash; Geoffrey A Block; Raymond R Townsend; Harold I Feldman; Edward R Smith; Andreas Pasch; Tamara Isakova
Journal:  Clin J Am Soc Nephrol       Date:  2019-10-28       Impact factor: 8.237

10.  The Management of Non-Dialysis-Dependent Chronic Kidney Disease in Primary Care.

Authors:  Gesine Weckmann; Jean-François Chenot; Sylvia Stracke
Journal:  Dtsch Arztebl Int       Date:  2020-10-30       Impact factor: 5.594

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.